Tirzepatide, a dual GIP and GLP-1 receptor agonist, mediates its anorexigenic effect in mice due to a reduction in homeostatic and reward-related feeding-论文-万方医学网

首页> > Tirzepatide, a dual GIP and GLP-1 receptor agonist, mediates its anorexigenic effect in mice due to a reduction in homeostatic and reward-related feeding

Tirzepatide, a dual GIP and GLP-1 receptor agonist, mediates its anorexigenic effect in mice due to a reduction in homeostatic and reward-related feeding

导出原文传递

翻译打印收藏纠错

第一作者： Samms, R.

作者： Samms, R. ^[1] ; Cosgrove, R. ; Antonellis, M. ; Droz, B. ; Roell, W. C. ; Sloop, K. W. ; Moyers, J. S. ; Matthew, M. ; Emmerson, P. J. ; Coskun, T.

作者单位： Eli Lilly & Co, Indianapolis, IN 46285 USA ^[1]

发布时间 2022-10-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Tirzepatide, a dual GIP and GLP-1 receptor agonist, mediates its anorexigenic effect in mice due to a reduction in homeostatic and reward-related feeding

相似文献

同项目论文

相关期刊

检索历史 清除

Tirzepatide, a dual GIP and GLP-1 receptor agonist, mediates its anorexigenic effect in mice due to a reduction in homeostatic and reward-related feeding

相似文献

同项目论文

相关期刊

检索历史清除